Evidence map›Paper›PMID 36416141›Full record

ArticleBioinformatics (Oxford, England)2023

Integrating heterogeneous knowledge graphs into drug-drug interaction extraction from the literature.

Masaki Asada, Makoto Miwa, Yutaka Sasaki

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Proceedings of machine learning research · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Masaki AsadaToyota Technological Institute, 2-12-1 Hisakata, Tempaku-ku, Nagoya, Aichi 468-8511, Japan.ORCID 0000-0002-7117-5962
Makoto MiwaToyota Technological Institute, 2-12-1 Hisakata, Tempaku-ku, Nagoya, Aichi 468-8511, Japan.ORCID 0000-0002-2330-6972
Yutaka SasakiToyota Technological Institute, 2-12-1 Hisakata, Tempaku-ku, Nagoya, Aichi 468-8511, Japan.ORCID 0000-0002-9556-7397

Funding

JSPS KAKENHI JP20K11962
6 · The paper itself

Abstract

motivationMost of the conventional deep neural network-based methods for drug-drug interaction (DDI) extraction consider only context information around drug mentions in the text. However, human experts use heterogeneous background knowledge about drugs to comprehend pharmaceutical papers and extract relationships between drugs. Therefore, we propose a novel method that simultaneously considers various heterogeneous information for DDI extraction from the literature.

resultsWe first construct drug representations by conducting the link prediction task on a heterogeneous pharmaceutical knowledge graph (KG) dataset. We then effectively combine the text information of input sentences in the corpus and the information on drugs in the heterogeneous KG (HKG) dataset. Finally, we evaluate our DDI extraction method on the DDIExtraction-2013 shared task dataset. In the experiment, integrating heterogeneous drug information significantly improves the DDI extraction performance, and we achieved an F-score of 85.40%, which results in state-of-the-art performance. We evaluated our method on the DrugProt dataset and improved the performance significantly, achieving an F-score of 77.9%. Further analysis showed that each type of node in the HKG contributes to the performance improvement of DDI extraction, indicating the importance of considering multiple pieces of information. AVAILABILITY AND IMPLEMENTATION: Our code is available at https://github.com/tticoin/HKG-DDIE.git.

Indexed as

Data MiningPattern Recognition, AutomatedDrug InteractionsHumansNeural Networks, ComputerPharmaceutical PreparationsPharmaceutical Preparations

Identifiers

PMID36416141
PMCPMC9805562

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.